Evidence map›Paper›PMID 27902700›Full record

ArticlePloS one2016

Plasma Lactoferrin Levels Positively Correlate with Insulin Resistance despite an Inverse Association with Total Adiposity in Lean and Severely Obese Patients.

Sylvain Mayeur, Alain Veilleux, Yves Pouliot, Benoît Lamarche, Jean-François Beaulieu, Frédéric S Hould, Denis Richard, André Tchernof, Emile Levy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sylvain MayeurResearch Centre CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Alain VeilleuxResearch Centre CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Yves PouliotInstitute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada.
Benoît LamarcheInstitute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada.
Jean-François BeaulieuDepartment of Anatomy and Cellular Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
Frédéric S HouldInstitut universitaire de cardiologie et de pneumologie de Québec, Quebec, Canada.
Denis RichardInstitut universitaire de cardiologie et de pneumologie de Québec, Quebec, Canada.
André TchernofInstitute of Nutrition and Functional Foods (INAF), Université Laval, Quebec, Quebec, Canada.
Emile LevyResearch Centre CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Université Laval · CAInstitut Universitaire de Cardiologie et de Pneumologie de Québec · CAUniversité de Montréal · CACentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextLactoferrin (Lf) is an important protein found on mucosal surfaces, within neutrophils and various cells, and in biological fluids. It displays multiple functions, including iron-binding as well as antimicrobial, immunomodulatory and anti-inflammatory activities. Although Lf ingestion has been suggested to cause adiposity reduction in murine models and humans, its relationship with insulin resistance (IR) has not been studied thoroughly.

objectiveTo establish the association between circulating Lf levels, glucose status and blood lipid/lipoprotein profile.

methodsTwo independent cohorts were examined: lean to moderately obese women admitted for gynecological surgery (n = 53) and severely obese subjects undergoing biliopancreatic diversion (n = 62).

resultsAlthough body mass index (BMI) and total body fat mass were negatively associated with Lf, IR (assessed by the HOMA-IR index) was positively and independently associated with plasma Lf concentrations of the first cohort of lean to moderately obese women. These observations were validated in the second cohort in view of the positive correlation between plasma Lf concentrations and the HOMA-IR index, but without a significant association with the body mass index (BMI) of severely obese subjects. In subsamples of severely obese subjects matched for sex, age and BMI, but with either relatively low (1.89 ± 0.73) or high (13.77 ± 8.81) IR states (according to HOMA-IR), higher plasma Lf levels were noted in insulin-resistant vs insulin-sensitive subjects (P<0.05). Finally, Lf levels were significantly higher in lean to moderately obese women than in severely obese subjects (P<0.05).

conclusionOur findings revealed that plasma Lf levels are strongly associated with IR independently of total adiposity, which suggests an intriguing Lf regulation mechanism in conditions of obesity and IR.

Indexed as

Insulin ResistanceAdiposityAdultBiomarkersBlood GlucoseCohort StudiesFemaleHumansLactoferrinLipidsLipoproteinsMaleMiddle AgedObesityThinnessBiomarkersBlood GlucoseLactoferrinLipidsLipoproteinsLTF protein, human

Identifiers

PMID27902700
PMCPMC5130198
OpenAlexW2558634696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.